Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
96,015,846
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
11,928,226
-
Shares change
-
-4,869,016
-
Total reported value, excl. options
-
$7,751,081
-
Value change
-
-$5,492,347
-
Put/Call ratio
-
13%
-
Number of buys
-
16
-
Number of sells
-
-20
-
Price
-
$0.6498
Significant Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q3 2022
56 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q3 2022.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,928,226 shares
of 96,015,846 outstanding shares and own 12% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (2,541,645 shares), VANGUARD GROUP INC (1,278,551 shares), Cormorant Asset Management, LP (1,154,424 shares), Redmile Group, LLC (696,377 shares), RENAISSANCE TECHNOLOGIES LLC (687,461 shares), BAKER BROS. ADVISORS LP (662,063 shares), Eversept Partners, LP (560,466 shares), BOXER CAPITAL, LLC (540,000 shares), Kynam Capital Management, LP (527,805 shares), and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (464,252 shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.